Peplomycin. DNA breakage and in vivo inhibition of DNA polymerases and ligase from human normal and leukemic cells.

Abstract : Peplomycin, a bleomycin-related cytostatic agent, was tested on DNA polymerases and DNA ligase. These enzymes were purified from normal human immunocompetent cells (thymocytes and lymphocytes) and from peripheral blast cells from different kinds of acute lymphoblastic and acute non-lymphoblastic leukemia. At low concentration ranges (1-25 microM) this compound was found to strongly inhibit polymerase alpha and ligase from leukemic cells while being less effective on the enzyme activity from normal thymocytes and lymphocytes. At the DNA level, low concentrations of peplomycin resulted in the induction of dose-dependent single-stranded breaks. The incubation of peplomycin (5 microM) with plasmid DNA resulted in its degradation as observed by agarose gel electrophoresis. Lowering the peplomycin concentration showed that ligase inhibition takes place prior to this phenomenon. The decreased formation of the ligase--adenylate complex under the effect of peplomycin is consistent with a direct interaction between the drug and the enzyme. These results are discussed in terms of possible selective cytostatic effects of peplomycin on leukemic cells.
Type de document :
Article dans une revue
Carcinogenesis, Oxford University Press (OUP), 1988, 9 (6), pp.965-70
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00966018
Contributeur : Claude Prigent <>
Soumis le : mercredi 26 mars 2014 - 08:05:19
Dernière modification le : mercredi 16 mai 2018 - 11:24:08

Identifiants

  • HAL Id : inserm-00966018, version 1
  • PUBMED : 2453304

Collections

Citation

Bénédicte Saulier, Claude Prigent, Raymonde Boutelier, Jean-Claude David. Peplomycin. DNA breakage and in vivo inhibition of DNA polymerases and ligase from human normal and leukemic cells.. Carcinogenesis, Oxford University Press (OUP), 1988, 9 (6), pp.965-70. 〈inserm-00966018〉

Partager

Métriques

Consultations de la notice

576